Biolevate raises €30M Series A and opens Boston office for its life sciences AI
4 Articles
4 Articles
Biolevate raises €30M Series A and opens Boston office for its life sciences AI
The Paris-based company Biolevate, which develops AI automation for use in regulated life sciences, has raised €30m in its Series A funding and has opened an office in Boston. Orange Ventures and RAISE France co-led the fundraising exercise, with the company stating that RAISE France is the investment arm of Aymar Hénin, a French entrepreneur. […] This story continues at The Next Web
Biolevate announces a series A of 30 million euros to deploy its artificial intelligence in the regulated operations of the health industries. The Parisian company no longer presents itself as a medical writing tool, it wants to organize the way in which the laboratories search, document, verify and validate their scientific knowledge. An ambition that ... L的article With 30 million euros, BIOLEVATE wants to make the AI a compliance tool for the …
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
